Magnetic stimulation allows focal activation of the mouse cochlea

  1. Jae-Ik Lee
  2. Richard Seist
  3. Stephen McInturff
  4. Daniel J Lee
  5. Christian Brown
  6. Konstantina M Stankovic  Is a corresponding author
  7. Shelley Fried  Is a corresponding author
  1. Massachusetts General Hospital, United States
  2. Massachusetts Eye and Ear Infirmary, United States

Abstract

Cochlear implants (CIs) provide sound and speech sensations for patients with severe to profound hearing loss by electrically stimulating the auditory nerve. While most CI users achieve some degree of open set word recognition under quiet conditions, hearing that utilizes complex neural coding (e.g., appreciating music) has proved elusive, probably because of the inability of CIs to create narrow regions of spectral activation. Several novel approaches have recently shown promise for improving spatial selectivity, but substantial design differences from conventional CIs will necessitate much additional safety and efficacy testing before clinical viability is established. Outside the cochlea, magnetic stimulation from small coils (micro-coils) has been shown to confine activation more narrowly than that from conventional micro-electrodes, raising the possibility that coil-based stimulation of the cochlea could improve the spectral resolution of CIs. To explore this, we delivered magnetic stimulation from micro-coils to multiple locations of the cochlea and measured the spread of activation utilizing a multi-electrode array inserted into the inferior colliculus; responses to magnetic stimulation were compared to analogous experiments with conventional micro-electrodes as well as to responses when presenting auditory monotones. Encouragingly, the extent of activation with micro-coils was ~60% narrower compared to electric stimulation and largely similar to the spread arising from acoustic stimulation. The dynamic range of coils was more than three times larger than that of electrodes, further supporting a smaller spread of activation. While much additional testing is required, these results support the notion that magnetic micro-coil CIs can produce a larger number of independent spectral channels and may therefore improve auditory outcomes. Further, because coil-based devices are structurally similar to existing CIs, fewer impediments to clinical translational are likely to arise.

Data availability

The source data and codes are available on the Open Science Framework (DOI 10.17605/OSF.IO/Y7ZRX).

The following data sets were generated

Article and author information

Author details

  1. Jae-Ik Lee

    Department of Neurosurgery, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9006-3405
  2. Richard Seist

    Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Stephen McInturff

    Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Daniel J Lee

    Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Christian Brown

    Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Konstantina M Stankovic

    Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, United States
    For correspondence
    kstankovic@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
  7. Shelley Fried

    Department of Neurosurgery, Massachusetts General Hospital, Boston, United States
    For correspondence
    fried.shelley@mgh.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6456-8656

Funding

National Institutes of Health (DC 01089)

  • Stephen McInturff
  • Daniel J Lee
  • Christian Brown

Fondation Bertarelli (Translational Neuroscience and Neuro-Engineering)

  • Stephen McInturff
  • Daniel J Lee
  • Christian Brown

National Institute on Deafness and Other Communication Disorders (R01 DC015824)

  • Richard Seist
  • Konstantina M Stankovic

Fondation Bertarelli (Bertarelli Professorship)

  • Richard Seist
  • Konstantina M Stankovic

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Brice Bathellier, CNRS, France

Ethics

Animal experimentation: All procedures were approved by the Institutional Animal Care and Use Committee of Massachusetts Eye and Ear, and carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals.(protocol# 15-003)

Version history

  1. Received: December 29, 2021
  2. Preprint posted: January 12, 2022 (view preprint)
  3. Accepted: May 20, 2022
  4. Accepted Manuscript published: May 24, 2022 (version 1)
  5. Version of Record published: June 8, 2022 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,112
    Page views
  • 248
    Downloads
  • 4
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jae-Ik Lee
  2. Richard Seist
  3. Stephen McInturff
  4. Daniel J Lee
  5. Christian Brown
  6. Konstantina M Stankovic
  7. Shelley Fried
(2022)
Magnetic stimulation allows focal activation of the mouse cochlea
eLife 11:e76682.
https://doi.org/10.7554/eLife.76682

Share this article

https://doi.org/10.7554/eLife.76682

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.